# Rilonacept in Diabetes Mellitus Type 1: Safety Study

> **NCT00962026** · PHASE1 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 13 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Rilonacept

## Key facts

- **NCT ID:** NCT00962026
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2013-03
- **Final completion:** 2013-06
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2014-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00962026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00962026, "Rilonacept in Diabetes Mellitus Type 1: Safety Study". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00962026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*